OTTMUSG00000018964 Inhibitors
The inhibition of the protein ovary testis transcribed involves a complex interplay of various signaling pathways and cellular processes. Trichostatin A, through its role as a histone deacetylase inhibitor, indirectly influences the expression of ovary testis transcribed by altering chromatin structure, thereby impacting its functional expression. Similarly, LY294002 and Wortmannin, both PI3K inhibitors, reduce the functional role of ovary testis transcribed in cell survival and growth by inhibiting the PI3K/AKT pathway. Rapamycin, targeting the mTOR pathway, and U0126 and PD98059, both targeting the MEK/ERK pathway, play crucial roles in inhibiting pathways that are vital for cell proliferation and survival, thus indirectly affecting the functional activity of ovary testis transcribed.
Furthermore, SB203580 and Sorafenib target the p38 MAPK and RAF/MEK/ERK signaling pathways, respectively, which are important for inflammatory responses, cell differentiation, and growth. Inhibition of these pathways can decrease the functional role of ovary testis transcribed in related cellular processes. SP600125, by inhibiting the JNK pathway, affects stress responses and apoptosis, indirectly impacting ovary testis transcribed. Bortezomib, a proteasome inhibitor, disrupts the degradation of regulatory proteins, creating an imbalance in the cellular processes where ovary testis transcribed is involved. Dasatinib and Gefitinib, by inhibiting Src family kinases and the EGFR pathway, respectively, also contribute to the indirect inhibition of the functional role of ovary testis transcribed in various cellular signaling pathways. Each of these chemicals, through their specific inhibitory actions on different pathways and processes, collectively contribute to the functional inhibition of ovary testis transcribed, highlighting the multifaceted approach required to modulate this protein's activity in cellular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, can indirectly inhibit ovary testis transcribed protein by altering the acetylation status of histones associated with its gene. This change in acetylation can lead to a more closed chromatin structure around the gene region of ovary testis transcribed, reducing its accessibility to transcriptional machinery and thereby decreasing its functional expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can inhibit the PI3K/AKT pathway, which is crucial for cell survival and growth. As ovary testis transcribed protein is involved in cell growth processes, inhibiting this pathway can indirectly reduce the functional role of ovary testis transcribed in these processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, can inhibit the mTOR pathway, which plays a significant role in cell growth and proliferation. The inhibition of this pathway can indirectly decrease the functional role of ovary testis transcribed protein in cell growth and survival processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, can inhibit the MEK/ERK pathway, which is involved in cell proliferation and survival. By inhibiting this pathway, U0126 can indirectly reduce the functional role of ovary testis transcribed protein in these cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, can inhibit the p38 MAPK pathway. This pathway is involved in inflammatory responses and cell differentiation. Inhibition of this pathway can indirectly reduce the functional role of ovary testis transcribed protein in related cellular processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor like LY294002, can also inhibit the PI3K/AKT pathway. This inhibition can indirectly reduce the functional role of ovary testis transcribed protein in cell survival and growth processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, can inhibit the JNK pathway, which is involved in stress responses and apoptosis. Inhibition of this pathway can indirectly reduce the functional role of ovary testis transcribed protein in these processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an ERK inhibitor, can inhibit the MEK/ERK pathway, similarly to U0126. This can lead to reduced functional role of ovary testis transcribed protein in cell proliferation and survival. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, can indirectly inhibit ovary testis transcribed protein by disrupting the degradation of regulatory proteins involved in its functional pathways, leading to an imbalance and dysfunction in the processes where ovary testis transcribed is involved. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a Src kinase inhibitor, can indirectly inhibit ovary testis transcribed protein by inhibiting Src family kinases, which play a role in various signaling pathways that may involve ovary testis transcribed protein's functional role. | ||||||